Feasibility, efficacy and cosmetic effect of three-dimensional conformal external beam partial breast irradiation for the selected early stage breast cancer patients after breast-conserving surgery
10.3760/cma.j.issn.1004-4221.2012.05.014
- VernacularTitle:早期乳腺癌保乳术后部分乳腺三维适形外照射的远期观察
- Author:
Min XU
;
Jianbin LI
;
Tingyong FAN
;
Qian SHAO
;
Jie LU
;
Chunxiang WANG
;
Jun XING
;
Yingjie ZHANG
;
Yongsheng WANG
;
Wenshu ZUO
- Publication Type:Journal Article
- Keywords:
Breast neoplasms/surgery;
Surgery, breast-conserving treatment;
Breast neoplasms/radiotherapy;
Radiotherapy,three-dimensional conformal;
Radiotherapy,partial breast;
Prognosis
- From:
Chinese Journal of Radiation Oncology
2012;21(5):439-442
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo explore the feasibility,efficacy and cosmetic effect of three-dimensional conformal external beam partial breast irradiation (EB-PBI) after breast-conserving surgery for the selected Chinese early stage breast cancer patients.MethodsFrom June 2003 to December 2010,Forty-four early stage breast cancer patients underwent EB-PBI after breast-conserving surgery.Twenty patients had CT simulation scan in moderate deep inspiration breathing hold,and twenty-four patients in free breathing.EB-PBI was planned and delivered by three-dimensional conformal radiotherapy (3DCRT)with four noncoplanar beams.The prescribed dose was 3.40 Gy per fraction in thirty-nine patients and 3.85 Gy per fraction in five patients,twice per day at an interval of at least six hours,in five consecutive days.Results The number of patients with follow up time of 2,3 and 5 years were 39,31 and 16.Grade 1 acute radiationinduced dermatitis was observed in 17 patients (39％) at three months.Cosmesis was good or excellent in all cases at six months after radiotherapy and in 95％ cases at two years after radiotherapy.The 2-,3-and 5-year local control rates were 100％,99％ and 94％,respectively.The 2-,3-,and 5-year survival rates were all 100％ and no metastases occurred.Conclusions EB-PBI delivered by 3DCRT is feasible for selected Chinese early stage breast cancer patients after breast-conserving surgery.The cosmetic effect,local control rate and long-term survival rate are satisfactory,and acute radiation toxicity is very low.
